Arkbio Launches Phase II Trial Of AK0610, For Respiratory
30 Oct 2025 //
PR NEWSWIRE
WHO Adds ArkBio`s Ziresovir to Pediatric RSV Drug Priority List
15 Jul 2025 //
PR NEWSWIRE
ArkBio`s ADHD drug Azstarys Granted Priority Review by China NMPA
15 Jun 2025 //
PR NEWSWIRE

Market Place
Sourcing Support